Pretreatment Plasma IL-6 and YKL-40 and Overall Survival after Surgery for Metastatic Bone Disease of the Extremities

SIMPLE SUMMARY: Estimating postoperative survival in patients undergoing surgery for metastatic bone disease of the extremities is important in order to choose an implant that will outlive the patient. The present study suggests that plasma IL-6, reflecting the inflammatory state of the patient, is...

Descripción completa

Detalles Bibliográficos
Autores principales: Sørensen, Michala Skovlund, Colding-Rasmussen, Thomas, Horstmann, Peter Frederik, Hindsø, Klaus, Dehlendorff, Christian, Johansen, Julia Sidenius, Petersen, Michael Mørk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201042/
https://www.ncbi.nlm.nih.gov/pubmed/34200156
http://dx.doi.org/10.3390/cancers13112833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201042/
https://www.ncbi.nlm.nih.gov/pubmed/34200156
http://dx.doi.org/10.3390/cancers13112833

Ejemplares similares